Botulinum Toxin Type A and Kinesitherapy of Post-stroke Patients

Active, not recruiting

Phase 3 Results N/A

Summary of Purpose

The objective of this study is to assess if the association of botulinum toxin type A and kinesitherapy is superior to kinesitherapy and 0,9% saline for the functional performance in post-stroke patients. Hypothesis H(0): BT-A associated to kinesitherapy is not superior to kinesitherapy in the function of hemiparetic post-stroke patients. H(1): BT-A associated to kinesitherapy is superior to kinesitherapy...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 December 2011.

1 Jun 2009 20 Oct 2009 1 Mar 2012 1 Apr 2012 1 Oct 2009 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

Not available